This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2015
Title: Elena La Porta: Innovator in Pharmaceutical Research
Introduction
Elena La Porta is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that serve as phosphodiesterase inhibitors. With a total of 2 patents, her work is crucial in addressing respiratory diseases.
Latest Patents
Elena's latest patents include innovative compounds that target the phosphodiesterase 4 (PDE4) enzyme. One of her notable inventions is focused on derivatives of 1-phenyl-2-pyridinyl alkyl alcohols, which are useful in preventing and treating diseases of the respiratory tract characterized by airway obstruction, such as asthma or COPD. Another patent involves phosphodiesterase-4 inhibitors belonging to the tertiary amine class, which are also aimed at treating specific medical conditions.
Career Highlights
Elena La Porta is currently employed at Chiesi Farmaceutici S.p.a., where she continues to advance her research in the pharmaceutical industry. Her expertise and innovative approach have positioned her as a key figure in her field.
Collaborations
Elena collaborates with talented professionals, including Elisabetta Armani and Andrea Rizzi, who contribute to her research endeavors.
Conclusion
Elena La Porta's work exemplifies the impact of innovation in pharmaceutical research. Her patents and collaborations highlight her commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile